Nootropil is the brand name for the leading Racetam which is a compound called Piracetam.
Specifically, Nootropil is a cyclic derivative of Gamma-Aminobutyric Acid (GABA). Despite this structure, it does not appear to effect GABA receptors within the brain.
Piracetam/Nootropil was first synthesized by the Romanian psychologist and chemist Dr. Corneliu E. Giurgea in 1964. After discovering the novel cognitive enhancing properties of this drug, Giurgea coined the term ‘nootropic’.
Internationally, this drug is used as a therapeutic agent in conditions such as cortical myoclonus, Down’s syndrome (DS), dyslexia in children, autism, aesthenia, tinnitus, vertigo, senile dementia, age-related cognitive decline, ADHD and some mood disorders.